|
|
|
Volumn 39, Issue 10, 2014, Pages 684-694
|
|
Pharmaceutical Approval Update
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
B LYMPHOCYTE RECEPTOR;
CENTRAL DEPRESSANT AGENT;
CHEMOKINE RECEPTOR CXCR4;
CHEMOKINE RECEPTOR CXCR5;
IDELALISIB;
OREXIN A;
OREXIN B;
PEGINTERFERON BETA1A;
PLACEBO;
RITUXIMAB;
SUVOREXANT;
ABNORMAL THINKING;
AMNESIA;
ANAPHYLAXIS;
ANXIETY;
APOPTOSIS;
ARTICLE;
AUTOIMMUNE HEPATITIS;
B CELL LYMPHOMA;
BEHAVIOR CHANGE;
BLOOD CELL COUNT;
CARDIOMYOPATHY;
CATAPLEXY;
CELL PROLIFERATION;
CELL VIABILITY;
CHRONIC LYMPHATIC LEUKEMIA;
COLITIS;
COMORBIDITY;
CONGESTIVE HEART FAILURE;
DEPRESSION;
DIARRHEA;
DRUG APPROVAL;
DRUG CLASSIFICATION;
DRUG INFORMATION;
EMBRYOTOXICITY;
EPIDERMOLYSIS;
FOOD AND DRUG ADMINISTRATION;
HALLUCINATION;
HEPATITIS;
HUMAN;
HYPERTHYROIDISM;
HYPERTRANSAMINASEMIA;
HYPOTHYROIDISM;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
INJECTION SITE NECROSIS;
INSOMNIA;
INTESTINE PERFORATION;
LIVER FAILURE;
LIVER INJURY;
LIVER TOXICITY;
LYMPHOCYTOMA;
MULTIPLE SCLEROSIS;
NEUTROPENIA;
NONHUMAN;
PARASOMNIA;
PHARMACEUTICAL CARE;
PNEUMONIA;
PREGNANCY;
RECOMMENDED DRUG DOSE;
RESPIRATORY FUNCTION;
SEIZURE;
SIGNAL TRANSDUCTION;
SOMNOLENCE;
SUICIDAL IDEATION;
SUICIDE;
WAKEFULNESS;
|
|
EID: 84907983741
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
